C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration

Brain Research

Volumn 1647, Issue , 2016, Pages 43-49

  Xiao, Shangxi ^a   MacNair, Laura ^a,b   McLean, Jesse ^a   McGoldrick, Phillip ^a   McKeever, Paul ^a,b   Soleimani, Serena ^a   Keith, Julia ^c   Zinman, Lorne ^c   Rogaeva, Ekaterina ^a   Robertson, Janice ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

ALS FTLD; C9 isoforms; C9 transcripts; C9orf72; Hexanucleotide repeat expansion

Indexed keywords

C9ORF72 PROTEIN; ISOPROTEIN; PROTEIN; SMITH MAGENIS SYNDROME CHROMOSOME REGION CANDIDATE 8; UNCLASSIFIED DRUG; WDR41 PROTEIN; C9ORF72 PROTEIN, HUMAN; REPETITIVE DNA;

AMYOTROPHIC LATERAL SCLEROSIS; FRONTOTEMPORAL DEMENTIA; MOTONEURON; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PURKINJE CELL; REVIEW; ANIMAL; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DNA REPEAT EXPANSION; FRONTOTEMPORAL LOBAR DEGENERATION; GENE EXPRESSION; HUMANS; MOTOR NEURONS; PROTEIN ISOFORMS; PROTEINS; PURKINJE CELLS;

EID: 84964746057     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.04.062     Document Type: Review

References (68)

1. Arai, T., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys. Res. Commun. 351 (2006), 602–611.
2. Ash, P.E., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77 (2013), 639–646.
3. Atanasio, A., et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep., 6, 2016, 23204.
4. Atkinson, R.A., et al. C9ORF72 expression and cellular localization over mouse development. Acta Neuropathol. Commun., 3, 2015, 59.
5. Bang, J., Spina, S., Miller, B.L., Frontotemporal dementia. Lancet 386 (2015), 1672–1682.
6. Behrends, C., et al. Network organization of the human autophagy system. Nature 466 (2010), 68–76.
7. Belzil, V.V., et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 126 (2013), 895–905.
8. Belzil, V.V., et al. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res. 1584 (2014), 15–21.
9. Boeynaems, S., et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep., 6, 2016, 20877.
10. Buratti, E., Baralle, F.E., The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 7 (2010), 420–429.
11. Ciura, S., et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis. Ann. Neurol., 2013.
12. Cleary, J.D., Ranum, L.P., Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders. Curr. Opin. Genet Dev. 26 (2014), 6–15.
13. DeJesus-Hernandez, M., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72 (2011), 245–256.
14. Donnelly, C.J., et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80 (2013), 415–428.
15. Farg, M.A., et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet., 2014.
16. Fratta, P., et al. Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta Neuropathol. 126 (2013), 401–409.
17. Freibaum, B.D., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525 (2015), 129–133.
18. Gami, P., et al. A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical disease. Acta Neuropathol. 130 (2015), 599–601.
19. Gijselinck, I., et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 11 (2012), 54–65.
20. Gijselinck, I., et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol. Psychiatry, 2015.
21. Haeusler, A.R., et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507 (2014), 195–200.
22. Irwin, D.J., et al. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol. 129 (2015), 469–491.
23. Jovicic, A., et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 18 (2015), 1226–1229.
24. Koonin, E.V., Aravind, L., Dynein light chains of the Roadblock/LC7 group belong to an ancient protein superfamily implicated in NTPase regulation. Curr. Biol. 10 (2000), R774–R776.
25. Koppers, M., et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol., 2015.
26. Lagier-Tourenne, C., et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U S A. 110 (2013), E4530–E4539.
27. Lee, Y.B., et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 5 (2013), 1178–1186.
28. Leonardy, S., et al. Regulation of dynamic polarity switching in bacteria by a Ras-like G-protein and its cognate GAP. EMBO J. 29 (2010), 2276–2289.
29. Levine, B., Kroemer, G., Autophagy in the pathogenesis of disease. Cell 132 (2008), 27–42.
30. Levine, T.P., et al. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics 29 (2013), 499–503.
31. Ling, S.C., Polymenidou, M., Cleveland, D.W., Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79 (2013), 416–438.
32. Liu, E.Y., et al. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol., 2014.
33. Lomen-Hoerth, C., Anderson, T., Miller, B., The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59 (2002), 1077–1079.
34. Marat, A.L., Dokainish, H., McPherson, P.S., DENN domain proteins: regulators of Rab GTPases. J. Biol. Chem. 286 (2011), 13791–13800.
35. Miertzschke, M., et al. Structural analysis of the Ras-like G protein MglA and its cognate GAP MglB and implications for bacterial polarity. EMBO J. 30 (2011), 4185–4197.
36. Mizielinska, S., Isaacs, A.M., C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function?. Curr. Opin. Neurol. 27 (2014), 515–523.
37. Mizuno-Yamasaki, E., Rivera-Molina, F., Novick, P., GTPase networks in membrane traffic. Annu Rev. Biochem. 81 (2012), 637–659.
38. Mizushima, N., et al. Autophagy fights disease through cellular self-digestion. Nature 451 (2008), 1069–1075.
39. Mori, K., et al. Bidirectional transcripts of the expanded C9orf72 Hexanucleotide Repeat Are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 126 (2013), 881–893.
40. Mori, K., et al. The C9orf72 GGGGCC repeat is translated Into aggregating Dipeptide-Repeat Proteins in FTLD/ALS. Science 339 (2013), 1335–1338.
41. Nakatogawa, H., et al. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat. Rev. Mol. Cell Biol. 10 (2009), 458–467.
42. Neumann, M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006), 130–133.
43. Ng, A.S., Rademakers, R., Miller, B.L., Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann. N Y Acad. Sci. 1338 (2015), 71–93.
44. O'Rourke, J.G., et al. C9orf72 is required for proper macrophage and microglial function in mice. Science 351 (2016), 1324–1329.
45. Renton, A.E., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72 (2011), 257–268.
46. Renton, A.E., Chio, A., Traynor, B.J., State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17 (2014), 17–23.
47. Ringholz, G.M., et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65 (2005), 586–590.
48. Schroder, B., et al. Integral and associated lysosomal membrane proteins. Traffic 8 (2007), 1676–1686.
49. Smith, T.F., Diversity of WD-repeat proteins. Subcell. Biochem. 48 (2008), 20–30.
50. Stirnimann, C.U., et al. WD40 proteins propel cellular networks. Trends Biochem Sci. 35 (2010), 565–574.
51. Strong, M.J., et al. A prospective study of cognitive impairment in ALS. Neurology 53 (1999), 1665–1670.
52. Strong, M.J., The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 9 (2008), 323–338.
53. Strong, M.J., et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10 (2009), 131–146.
54. Swinnen, B., Robberecht, W., The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 10 (2014), 661–670.
55. Therrien, M., et al. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. Plos. One., 8, 2013, e83450.
56. Tran, H., et al. Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS. Neuron 87 (2015), 1207–1214.
57. van Blitterswijk, M., DeJesus-Hernandez, M., Rademakers, R., How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?. Curr. Opin. Neurol. 25 (2012), 689–700.
58. van Blitterswijk, M., et al. Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72. Acta Neuropathol. 130 (2015), 863–876.
59. van der Zee, J., Van Broeckhoven, C., Dementia in 2013: frontotemporal lobar degeneration-building on breakthroughs. Nat. Rev. Neurol. 10 (2014), 70–72.
60. Waite, A.J., et al. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging, 2014.
61. Xi, Z., et al. Hypermethylation of the CpG Island Near the GC Repeat in ALS with a C9orf72 Expansion. Am. J. Hum. Genet., 2013.
62. Xi, Z., et al. Hypermethylation of the CpG-island near the C9orf72 G(4)C(2)-repeat expansion in FTLD patients. Hum. Mol. Genet. 23 (2014), 5630–5637.
63. Xi, Z., et al. Jump from pre-mutation to pathologic expansion in C9orf72. Am. J. Hum. Genet., 2015.
64. Xi, Z., et al. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol. 129 (2015), 715–727.
65. Xiao, S., et al. Isoform specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann. Neurol. 78 (2015), 568–583.
66. Zhang, D., et al. Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front. Genet., 3, 2012, 283.
67. Zhang, K., et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525 (2015), 56–61.
68. Zu, T., et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. USA 110 (2013), E4968–E4977.